There’s only so much the test can actually tell you about breast cancer.
The Food & Drug Administration is finally allowing 23andMe to provide testing for the breast cancer-related genes BRCA1 and 2. Back in 2013, when the direct-to-consumer company originally starting selling the test, the FDA clamped down and forced 23andMe to verify its genetic health risk evaluations. 23andMe had to prove the genes they were testing for were related to a health condition, and show that the tests were accurate.
